Data science is shaping our discovery and development efforts
We are using advanced data science and neuroinformatics to map drug targets to specific brain circuitry and corresponding behaviors.
Stay informed about our latest developments
- October 11, 2018 BlackThorn Therapeutics Announces Participation in Key Data Science and Cloud Computing Panels to Advance Therapeutic Development at 2018 BIO Investor Forum
- August 6, 2018 BlackThorn Therapeutics Announces Exclusive Licensing Agreement and Extension of Key Collaboration with Yale University
- June 12, 2018 BlackThorn Therapeutics Names George S. Golumbeski, Ph.D., to Board of Directors